Allarity Therapeutics, Inc. Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants
Allarity Therapeutics, Inc. (ALLR) reported Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants of 16.43 million shares for the 12-month period ending 2023-09-30, per its 10-Q filed 2023-11-14.
Discontinued › Income Statement › Earnings Per Share
us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants · last filed 2023-11-14
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 1 month | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 1 month as first filed | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 12 month |
|---|---|---|---|
| 2023-09-30 | 16.43M shares 10-Q · filed 2023-11-14 | ||
| 2022-09-30 | 2.03M shares 10-Q · filed 2023-11-14 | ||
| 2021-09-30 | 3.50M shares 10-Q · filed 2022-11-14 | ||
| 2021-06-30 | 3.50M shares 10-Q · filed 2022-10-07 | ||
| 2021-03-31 | 1.09M shares 10-Q · filed 2022-05-27 | ||
| 2020-02-29 | 79.94K shares 10-Q/A · filed 2022-05-17 | 4.00M shares 10-Q · filed 2021-11-23 | |
| 2020-02-23 | 79.94K shares 10-K · filed 2023-03-13 | ||
| 2014-12-17 | 570.00K shares 10-K · filed 2023-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |